(±)-Naringenin
-
(±)-Naringenin
structure -
-
CAS No:
67604-48-2
-
Formula:
C15H12O5
-
Chemical Name:
(±)-Naringenin
-
Synonyms:
4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-;2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;4′,5,7-Trihydroxyflavanone;5,7,4′-Trihydroxyflavanone;(R,S)-Naringenin;(±)-Naringenin;(RS)-Naringenin;(±)-5,7,4′-Trihydroxyflavanone;ST 057236;5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chroman-4-one;5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one;TCI-CA 03;93602-28-9
- Categories:
-
CAS No:
Description
(±)-Naringenin is a naturally-occurring flavonoid. (±)-Naringenin displays vasorelaxant effect on endothelium-denuded vessels via the activation of BKCa channels in myocytes[1].
Naringenin is a trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 6 and 4'. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones.
(±)-Naringenin Basic Attributes
272.25
272.25
266-769-1
34875|11855
DTXSID1022392|DTXSID50274239
29329990
Characteristics
87
2.4
1.485g/cm3
248 °C
577.5°C at 760 mmHg
soluble in ethanol (50 mg/ml), DMSO, methanol, and ammonium hydroxide (50 mg/ml). Insoluble in water (almost)
0-6°C
167.96 Ų [M+H]+ [CCS Type: DT, Method: stepped-field]|167.33 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|160.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
3077
3
36/37/38
26-36
DJ2981530
Xi
P261-P305 + P351 + P338
H315-H319-H335
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 200 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)|Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Narigenin has known human metabolites that include Narigenin 7-O-glucuronide.
4',5,7-trihydroxyflavanone
(±)-Naringenin Use and Manufacturing
The aglucon of Naringin. Inhibitory mechanism of Naringenin against carcinogenic acrylamide formation and nonenzymic browning in Maillard model reactions
Computed Properties
Molecular Weight:272.25
XLogP3:2.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:1
Exact Mass:272.06847348
Monoisotopic Mass:272.06847348
Topological Polar Surface Area:87
Heavy Atom Count:20
Complexity:363
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of (±)-Naringenin
-
CN
3 YRS
Business licensedTrader Supplier of Apigenin,PQQ,NMNHInquiryCAS No.: 67604-48-2Grade: Chemical GradeContent: 99% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Herb Extracts,Cosmetic raw materails,API -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 67604-48-2Grade: Industrial GradeContent: 99%
Learn More Other Chemicals
-
25-Deoxyecdysone
22005-50-1
-
compoundk
160729-91-9
-
7-[4-[4-(2-bromophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
203395-84-0
-
Moscatilin Formula
108853-14-1
-
beta-sitosterol sulfate Formula
24815-93-8
-
Cocoa butter Formula
8002-31-1
-
(2β,3β,5β,22S)-22,25-Epoxy-2,3,14,20-tetrahydroxycholest-7-en-6-one Structure
26361-67-1
-
escin IIa Structure
158732-55-9
-
What is Carvacryl acetate
6380-28-5
-
What is 13,28-Epoxy-16β-hydroxyolean-11-en-3β-yl 6-deoxy-3-O-(β-D-glucopyranosyl)-β-D-galactopyranoside
64340-44-9